1. June 23, 2020

    Exploring clinical trials for breast cancer

    Learn about the latest clinical trials for breast cancer.

  2. June 23, 2020

    Signs of high risk breast cancer

    Learn about the latest innovations for high risk breast cancer.

  3. June 04, 2020

    Cutting-edge treatment and research for brain tumors

    Mayo Clinic neurologists and neurosurgeons discuss the most advanced treatments and the future of brain tumor therapy.

  4. Jan. 27, 2020

    Treatment innovations for pancreatic adenocarcinoma

    Learn about the latest treatment innovations for pancreatic adenocarcinoma and how these innovations have extended survival.

  5. Jan. 27, 2020

    Symptoms and treatment of pancreatic neuroendocrine tumors

    How to spot the symptoms of pancreatic neuroendocrine tumors so your patients can receive the right treatment.

  6. Dec. 05, 2019

    Minimally invasive surgery, sentinel lymph node biopsy produce excellent perioperative outcomes for patients with endometrial cancer

    Andrea Mariani, M.D., M.S., a gynecological surgeon at Mayo Clinic in Rochester, Minnesota, discusses the importance of minimally invasive surgery and sentinel nodes in the evolution of surgical treatment of endometrial cancer.

  7. Nov. 05, 2019

    Robotic bronchoscopy

    Robotic bronchoscopy uses flexible robotics that enable new possibilities in endoscopy. Karen L. Swanson, D.O., pulmonologist at Mayo Clinic in Arizona, shares the latest on robotic bronchoscopy and looks ahead to what this means for lung cancer.

  8. Oct. 31, 2019

    HPV-related oropharynx cancer discoveries

    Experts from Mayo Clinic's Head and Neck Cancer Center discuss the latest discoveries in HPV-related oropharynx cancers and the importance of spotting symptoms to ensure your patient receives the tests needed to diagnose and treat the cancer.

  9. Sept. 18, 2019

    Newly discovered autoimmune disease associated with testicular cancer

    Sean J. Pittock, M.D., an autoimmune neurologist at Mayo Clinic, discusses a newly discovered autoimmune disease that appears to affect men with testicular cancer.

  10. Aug. 28, 2019

    Multifocal lung cancer discussion and case presentation

    Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares a case presentation on VATS left lower lobectomy in the setting of multiple lung lesions.

  11. Aug. 28, 2019

    Minimally invasive approach to Pancoast tumor using 3D printing

    Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares a case presentation on hybrid Pancoast tumor resection.

  12. Aug. 28, 2019

    How to do 3D modeling for cardiothoracic surgery

    Shanda Blackmon, M.D., M.P.H., professor of surgery and thoracic surgeon at Mayo Clinic in Rochester, Minnesota, shares how to use 3D modeling for CT surgery.

  13. Aug. 20, 2019

    Gastric cancer overview

    Travis E. Grotz, M.D. discusses stomach (gastric) cancer risks, signs and symptoms, diagnosis, staging, and treatments including hyperthermic intraperitoneal chemotherapy (HIPEC) and immunotherapy.

  14. July 26, 2018

    Recurrent ovarian cancer: Treatment and clinical trials

    There are many options available to treat recurrent ovarian cancer, even if it has recurred more than once. Recurrence is common in patients with ovarian cancer.

  15. July 26, 2018

    Clinical trial regarding endometrial cancer and stress urinary incontinence

    Gynecologic oncologist Gretchen E. Glaser, M.D., with Mayo Clinic in Rochester, Minnesota, discusses a study that compares the quality of life and clinical outcomes among women with endometrial cancer and stress urinary incontinence who have concurrent surgery with that of women who do not have concurrent surgery.

  16. July 26, 2018

    Obesity and endometrial cancer

    Women who are obese are six times more likely to develop endometrial cancer than women who maintain a healthy weight. Amanika Kumar, M.D., discusses the relationship between obesity and endometrial cancer and treatment to ensure long-term, sustainable weight loss.

  17. March 17, 2017

    Advances in colorectal cancer screening

    Mayo Clinic physicians John B. Kisiel, M.D., and David W. Larson, M.D., M.B.A., discuss the latest advancements in colorectal cancer screening, as well as the latest surgical techniques available for people with colorectal cancer.

  18. March 08, 2017

    Demystifying sarcoma

    Medical oncologists, Scott H. Okuno, M.D., Steven I. Robinson, M.B.B.S., and orthopedic surgeon, Peter S. Rose, M.D., discuss sarcomas — a group of rare soft tissue and bone cancers — and the unique treatment options for these cancers.

  19. Feb. 28, 2017

    A multidisciplinary approach to genitourinary cancers

    Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer.

  20. Jan. 19, 2017

    Unlocking the power of gene expression: Molecular classification of brain tumors

    Mayo Clinic physicians and researchers discuss how the molecular makeup of brain tumors can be used to identify five categories of gliomas, each with different clinical features and outcomes.

  21. Jan. 09, 2017

    Chromoendoscopy for inflammatory bowel disease

    Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease.

  22. June 10, 2016

    Researchers identify best drug therapy for rare, aggressive pancreatic cancer

    Each year, about 200 to 400 Americans develop acinar cell carcinoma, a rare form of pancreatic cancer that has no effective standard of care.

  23. March 01, 2016

    Radiation therapy associated with a lower risk of recurrence in people with pancreatic cancer

    Radiation therapy improves survival times in patients who are candidates for pancreatic cancer surgery.

  24. Aug. 05, 2015

    Methylated DNA markers and whole-body cancer screening

    John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors.

  25. July 22, 2015

    Stem cell transplantation as a treatment for multiple myeloma — Mayo Clinic

    Multiple myeloma is a cancer of the plasma cells, which are found in the bone marrow or blood-producing tissue that fills spaces within the bones.

  26. July 22, 2015

    Treatment for people with cholangiocarcinoma at Mayo Clinic

    Rory L. Smoot, M.D., describes treatment options and the specialized team of experts at Mayo Clinic who provide care for patients with cholangiocarcinoma.

  27. June 09, 2015

    Proton therapy has advantages over IMRT for advanced nasal cavity and paranasal sinus cancer

    Robert L. Foote, M.D., comments on findings of a new study by radiation oncologists at Mayo Clinic, comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base.

  28. April 09, 2015

    Surgical treatment options for people with prostate cancer

    Igor Frank, M.D., discusses surgical treatment options for people with prostate cancer.

  29. Nov. 05, 2014

    Bladder cancer treatment options

    R. Jeffrey Karnes, M.D., consultant and associate professor, Mayo Clinic, discusses treatment options for bladder cancer. The ailment can be subdivided into subcategories, and the treatments dramatically differ. Invasive treatments can include an ileal neobladder created from the patient's small intestine, which can provide the best quality of life.

  30. Oct. 08, 2014

    Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients

    Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

  31. Oct. 08, 2014

    Precursor of multiple myeloma more common in blacks than whites, Mayo study finds

    Blacks may be twice as likely as whites to develop multiple myeloma because they are also more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance.

  32. Oct. 07, 2014

    Minority disparities evident in prostate cancer survival rate, Mayo Clinic study shows

    A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk of poorer survival rate following prostate cancer treatment compared with other minority groups.

  33. Oct. 06, 2014

    Tissue testing during breast cancer lumpectomies prevents need for re-operation 96 percent of time

    Unique laboratory testing during breast cancer lumpectomies to make sure surgeons removed all the cancerous tissue spares patients the need for a repeat operation in roughly 96 percent of cases at Mayo Clinic in Rochester, Minnesota.

  34. Oct. 06, 2014

    Chemo after radiation therapy improves brain cancer survival

    A clinical trial co-led by Mayo Clinic Cancer Center researchers found that adding chemotherapy following radiation treatment improved survival for adults with low-grade gliomas by more than five years.

  35. Oct. 01, 2014

    Less-radical procedures offer similar cancer control compared with surgery for kidney cancer patients

    Needle-guided tumor destruction procedures offer near-equivalent lengths of local cancer control compared with surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.

  36. Aug. 13, 2014

    Mesalamine dose may lower marker of bowel inflammation

    Edward V. Loftus Jr., M.D., discusses an article looking at the ability of a drug to drive down calprotectin, a marker of bowel inflammation, in people who have ulcerative colitis.

  37. July 08, 2014

    Mayo Clinic researchers help to shine new light on bladder cancer tumors

    Mayo Clinic researchers help to shine new light on bladder cancer tumors.

  38. June 27, 2014

    PROMOTE: Prostate Cancer Medically Optimized Genome Enhanced Therapy Study

    The Prostate Cancer Medically Optimized Genome Enhanced Therapy Study (PROMOTE) aims to individualize treatments for men with castration-resistant prostate cancer.

  39. June 17, 2014

    Grand Rounds: Less Invasive Axillary Surgery After Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071

    Judy C. Boughey, M.D., presents Less Invasive Axillary Surgery after Neoadjuvant Chemotherapy in Women who Present With Node-Positive Breast Cancer — Results From a Prospective Clinical Trial: ACOSOG Z1071.

  40. May 22, 2014

    Choline C-11: Pulling back the curtain on prostate cancer

    Mayo Clinic has integrated production, imaging and pathology facilities to provide the benefit of Choline C 11 PET imaging to prostate cancer patients.

  41. March 11, 2014

    Robotic neobladder procedure

    Mayo Clinic's Erik P. Castle, M.D., and Mitchell R. Humphreys, M.D., explain and demonstrate the neobladder procedure.

  42. March 03, 2014

    Prostate cancer developments — Mayo Clinic Proceedings

    Manish Kohli, M.D., of Mayo Clinic, discusses his January 2010 Mayo Clinic Proceedings article on new developments in the medical management of prostate cancer.

  43. March 03, 2014

    Predictors of ADT response in advanced prostate cancer

    Manish Kohli, M.D., associate professor of medical oncology at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the March 2012 issue of Mayo Clinic Proceedings.

  44. March 03, 2014

    New developments in the medical management of prostate cancer

    Manish Kohli, M.D., of Mayo Clinic, discusses his January 2010 Mayo Clinic Proceedings article on new developments in the medical management of prostate cancer.

  45. March 03, 2014

    Mayo Clinic study suggests routine prostate size evaluation not as effective in cancer screening

    If a man's PSA is quickly rising, he likely deserves a prostate biopsy to determine if he has prostate cancer. Assessment of change in prostate size should not influence the decision to biopsy. Dr. Rodney Breau discusses the study and its findings in this video.

  46. Feb. 28, 2014

    Malignant fibrous histiocytoma in CLL and Non-Hodgkin lymphoma

    Jerry D. Brewer, M.D., M.S., a dermatologic surgeon in the Department of Dermatology at Mayo Clinic in Rochester, Minnesota, discusses his article appearing in the August 2011 issue of Mayo Clinic Proceedings.

  47. Feb. 28, 2014

    Gene is linked to lung cancer development in never smokers

    A five-center collaborative study that scanned the genomes of thousands of "never smokers" diagnosed with lung cancer as well as healthy never smokers has found a gene they say could be responsible for a significant number of those cancers.

  48. Feb. 28, 2014

    DNA stool test for colon cancer — Mayo Clinic

    Doctors at Mayo Clinic have studied and improved upon a noninvasive screening test that requires no preparation or procedure. The test detects cancer or precancerous polyps by measuring DNA in your stool.

  49. Feb. 28, 2014

    Diagnosing and managing patients with BRCA mutations

    Sandhya Pruthi, M.D., consultant in the Breast Diagnostic Clinic at Mayo Clinic in Rochester, Minnesota, discusses her December 2010 Mayo Clinic Proceedings article on diagnostic and management approaches to patients with BRCA mutations that put them at higher risk of breast and ovarian cancers.

  50. Feb. 28, 2014

    Common musculoskeletal tumors of childhood and adolescence

    Carola A S. Arndt, M.D., a pediatric hematologist from Mayo Clinic in Rochester, Minnesota, discusses her article appearing in the May 2012 issue of Mayo Clinic Proceedings.

  51. Feb. 28, 2014

    Biopsy-based predictors of prostate cancer mortality: The Mayo Model

    Matthew K. Tollefson, M.D., provides patients and clinicians with a novel way to predict which cases of prostate cancer, the most commonly diagnosed malignancy in American men, will be aggressive and which ones can be safely monitored with watchful waiting.

  52. Feb. 28, 2014

    Aromatase inhibitors in breast cancer survivors

    Sandhya Pruthi, M.D., director of the Breast Diagnostic Clinic at Mayo Clinic's campus in Rochester, Minnesota, discusses her article on managing aromatase inhibitors in breast cancer survivors.

  53. Feb. 28, 2014

    16-year longitudinal changes in serum prostate-specific antigen (PSA) levels

    Jennifer St. Sauver, Ph.D., associate professor of epidemiology in the Department of Health Sciences Research at Mayo Clinic in Rochester, Minnesota, discusses her article appearing in the January 2012 issue of Mayo Clinic Proceedings.

  54. Feb. 27, 2014

    Mayo Pancreas Clinic among world's best

    Santhi Swaroop Vege, M.D., explains what distinguishes the Pancreas Clinic at Mayo Clinic's campus in Minnesota from other elite centers, including renowned specialists devoted exclusively to pancreatic disease.

  55. Feb. 04, 2014

    Study shows potential to prevent hospitalizations in brain tumor patients

    In a retrospective five-year study, researchers at Mayo Clinic found that common causes of hospitalization for patients with malignant brain tumors, such as seizures, are potentially preventable.